News

CollPlant's BioInk Surpasses Matrigel in Tissue Engineering Study

CollPlant's BioInk Surpasses Matrigel in Tissue Engineering Study

CollPlant BioInk Outperforms Matrigel in Recent Study

A pioneering study conducted by Israel's Technion has revealed that CollPlant's rhCollagen-based bioink, Collink.3D™, has surpassed the performance of Matrigel, a well-established extracellular matrix, in supporting structured tissue formation.

Results of the Comparative Study

The Technion study resulted in significant findings that showcase how Collink.3D™ offers potential as a consistent, tunable, and animal-free alternative ideal for advanced tissue engineering and research applications. The study demonstrated that Collink.3D™ offers enhanced mechanical properties that contribute to better outcomes in tissue regeneration.

Importance of Extracellular Matrices

Extracellular matrices play a vital role in various fields such as drug discovery, regenerative medicine, and tissue modeling. CollPlant’s plant-based technology stands out by delivering a sustainable and ethical solution that maintains high performance, making it a favorable choice for researchers and practitioners alike.

Collink.3D™: A Breakthrough in BioInk Technology

Collab, developed by CollPlant Biotechnologies (Nasdaq: CLGN), is a recombinant human collagen-based bioink that exhibits impressive characteristics. In addition to outperforming Matrigel in the study, Collink.3D™ provides an environment conducive to organized and long-lasting tissue formation, highlighting its role as a next-generation extracellular matrix.

Market Overview

The market for basement membrane matrices, including Matrigel and similar products, is on an upward trajectory; it is estimated to be valued at approximately $96 million in 2024 and projected to reach $201 million by 2031, with a substantial growth rate. Major suppliers dominate the market including Corning, Thermo Fisher Scientific, and R&D Systems, holding a significant market share.

CEO's Remarks on the Study

CollPlant’s CEO, Yehiel Tal, expressed optimism regarding the study’s outcomes: "We are thrilled with the results from the Technion study. This solidifies Collink.3D™ as a highly supportive and durable bioink, fostering cell organization and tissue development while preserving structural integrity. We strongly believe that this product represents a promising, animal-free alternative for tissue engineering and regenerative medicine applications."

Exploring the Future of Collink.3D™

Collink.3D™ is crafted from genetically engineered plants and is devoid of any animal-derived ingredients. As the first and only plant-based human collagen bioink platform, it closely mirrors the innate properties of human tissues, opening doors for scalable biofabrication in creating complex 3D models such as organ structures and scaffolds.

CollPlant's Vision and Future Plans

CollPlant is leading a transformative shift in regenerative and aesthetic medicine, with a focus on the innovative bioprinting of tissues and organs. Their efforts extend to tissue repair and aesthetics, developed through their proprietary rhCollagen technology, which addresses a diverse range of medical needs.

In a notable partnership, CollPlant secured a development deal with Allergan, part of AbbVie, which marks a significant advancement in the dermal filler market. This collaboration is set to enhance their presence and capabilities within the industry.

Frequently Asked Questions

What is Collink.3D™?

Collink.3D™ is a recombinant human collagen-based bioink designed for tissue engineering, manufactured using genetically engineered plants without animal-derived substances.

How does Collink.3D™ compare to Matrigel?

The recent study indicates that Collink.3D™ outperforms Matrigel in mechanical strength, elasticity, and stability, providing superior support for tissue formation.

What are extracellular matrices used for?

Extracellular matrices are indispensable in drug discovery, regenerative medicine, and tissue modeling, acting as a foundation for cell growth and tissue development.

Who is the CEO of CollPlant?

Yehiel Tal is the Chief Executive Officer of CollPlant, overseeing the company’s innovative approach to regenerative medicine.

What is the market projection for bioinks?

The basement membrane matrix market is projected to grow from approximately $96 million in 2024 to $201 million by 2031, indicating an annual growth rate of around 11.2%.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Breaking Down Oklahoma's Car Insurance Costs

Updated Category News Views 47

Understanding Car Insurance Dynamics in Oklahoma In the labyrinth of car insurance premiums, drivers in Oklahoma are left navigating a multitude of factors. A recent article from HelloNation, featuring insurance agent Bobby Williamson, dives into these elements with a candor that cuts through the fluff. Understanding what drives those numbers up or down isn't just for the...

Continue Reading
AI Deepfakes Met Their Match: IC-Corp's New Patent

Updated Category News Views 179

The Deepfake Fraud Reality Slap You know, in a world where you can't trust your own eyes on a video call, trust gets a bit sketchy, right? Imagine this scenario—an unsuspecting finance employee, surrounded by familiar faces and voices, only to wind up sending $25.6 million to fraudsters who weren't even real. A chilling real-world example from January 2024, courtesy of...

Continue Reading
GM Ditches NYSE for Nasdaq: What to Expect?

Updated Category News Views 65

The Big Migration: GM Moves to Nasdaq You know when an old dog changes its turf, it's looking for some new tricks. General Motors (NYSE: GM) has decided to pack its bags and leave the New York Stock Exchange (NYSE) for the Nasdaq Global Select Market. They’re sticking with the same ticker, "GM," but you can expect that big switcheroo come November 17, 2026. I can't be...

Continue Reading
Co-Diagnostics Nearing India TB Test Launch By 2026

Updated Category News Views 0

Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...

Continue Reading
HIMS Lawsuit: Investors Under the Gun Before Deadline

Updated Category News Views 71

HIMS Investors Find Themselves in Hot Water Well, it looks like the ball's in your court, folks. Hims & Hers Health, Inc. (NYSE: HIMS) has been caught in a whirlwind of legal drama, and if you're holding any $HIMS stock, you've got some decisions to make—and fast. With a looming November 2 deadline to step up in a securities class action, this is one of those...

Continue Reading
Switchgear Monitoring Market Surges to $3.80 Billion

Updated Category News Views 31

Switchgear Monitoring: A Crucial Component in Modern Power Grids When the chips are down, it's the grid that keeps the lights on. Now, looks like switchgear monitoring systems are riding high on this global necessity. Fueled by infrastructure upgrades, the market's slated to leap from $2.36 billion in 2026 to a whopping $3.80 billion by 2031, clocking a solid 10.1% CAGR....

Continue Reading
Webull Faces Investor Lawsuit: Compliance in Question

Updated Category News Views 97

Webull's Run into Regulatory Fog Well, here we go—another tech company caught with its pants down over alleged ties with China. Webull Corporation (NASDAQ:BULL) is in the crosshairs of a class action lawsuit. Investors are sharpening their pitchforks, and you've got until December 7, 2026, to throw your hat in the ring as lead plaintiff. The Core of the Allegations...

Continue Reading
EDGE Sound Research Boosted by $2M from Stormbreaker

Updated Category News Views 0

EDGE Sound Research: Shaping Future with Sound Folks are starting to whisper more about EDGE Sound Research these days, and for good reason. This little outfit based out of Riverside, California just took in another $2 million from Stormbreaker Ventures, lifting its total funding to $9 million. But what are they doing with all that cash? They're building the perception...

Continue Reading
XCMG Lends Heavy Equipment to Nairobi Rescue Effort

Updated Category News Views 35

When Buildings Fall and Heavy Equipment Matters Buildings aren't supposed to just topple over. It's not some new trend I missed, but when it does happen, you've got a crisis – and that's exactly what unfolded in Nairobi on October 23 when an 18-story tower gave out, crashing down into chaos in the Eastleigh neighborhood. From Ground Zero to Immediate Response Imagine...

Continue Reading
Exploring Family, Faith, and Forgiveness in New Book

Updated Category News Views 134

Diving into the Depths of Faith and Forgiveness T.L. Dennis ain't just spinning a yarn about his childhood in "A Conversation with a Dead Father". This is a deep dive into the gritty realities of his relationship with his old man, seasoned with the salt of personal struggles and spiritual redemption. The pages of this book open at the one place none of us look for good...

Continue Reading

Top 5 Most Recently Viewed Articles

Indivior PLC Enhances Reporting Standards to Attract Investors

Updated Category News Views 207

Indivior Makes a Strategic Shift to US GAAP Reporting Indivior PLC (NASDAQ: INDV), a prominent global pharmaceutical company, has recently announced its transition to U.S. Generally Accepted Accounting Principles (GAAP). This significant shift is part of their broader strategy to move its primary stock listing to the United States, a decision aimed at increasing interest...

Continue Reading
Carlsmed's Strategic Growth with New Medicare Reimbursement

Updated Category News Views 172

Carlsmed's Innovative Approach to Spine Surgery Carlsmed Inc. (NASDAQ: CARL) stands at the forefront of innovation in the spinal implant sector. Armed with artificial intelligence technology, Carlsmed aims to revolutionize spine surgery with personalized solutions. Recent advancements in their products and favorable analyst outlooks signal a promising trajectory for the...

Continue Reading
Harvey and LexisNexis Team Up for Enhanced Legal AI Workflows

Updated Category News Views 416

Harvey and LexisNexis Forge a New Era in Legal Technology Exciting news is unfolding in the legal tech landscape as Harvey and LexisNexis join forces. This strategic alliance is set to revolutionize the ways legal professionals access and utilize information. By integrating LexisNexis generative AI technology and its rich collection of legal content into the Harvey...

Continue Reading
Culture Partners Reveals Over 14,000 Presales for New Leadership Book

Updated Category News Views 100

Culture Partners' Book Achieves Notable Sales Ahead of Launch The anticipation builds as Culture Partners, under the visionary leadership of CEO Joe Terry, announces that their upcoming publication, Surrender to Lead, has impressively surpassed 14,000 presales. This surge in interest reflects a strong demand for effective leadership strategies in an evolving business...

Continue Reading
LHV Group's Recent Share Acquisition Insights and Impact

Updated Category News Views 113

Overview of Recent Share Acquisitions by LHV Group LHV Group recently announced significant developments regarding its share acquisitions, undertaken between December 5 and December 11, 2025. This initiative showcases the company’s commitment to enhancing shareholder value and increasing their stake in the market. Such moves are often indicative of a company's strong...

Continue Reading